Despite all the near-death experiences for that startup, Holmes continues to take even the small steps necessary to save the company - and herself. But the odds are against that.
The latest move, reports MarketWatch, is agreeing to accept the feds' two-year ban on being part of the blood-testing industry. In exchange, the company will receive a lesser penalty. But this is almost symbolic, not real.
When originally threatened with this ban, Theranos made the strategic switch from being a consumer facility which directly tested blood to a technology company selling to third parties. Currently it is developing the MiniLab, which is a remote technology that, the company claims, will be able to test blood anywhere.
But, Theranos could still be crushed by two factors. They are the ongoing civil and criminal investigations by the feds and second are the investor and consumer lawsuits.
For a time, superlawyer David Boies represented Theranos and Holmes. But they split over what members of the media described as disagreements about handing the regulatory challenges.
Many remember the days when Theranos was a high flyer. Then The Wall Street Journal published an article questioning the accuracy of its technology. That was the beginning of the end.
The amazing thing is that the end hasn't come yet. Some predict that because of the lawsuits Holmes will have to file for bankruptcy. It had been reported not to have the financial reserves to fund fighting the litigation.
Place your sponsored content and links on Jane Genova's syndicated sites.
Inbound links range from Bloomberg to Bing to AOL.
High rankings on Google.
Complimentary Consultation email@example.com.